
Former Bellamy’s chairman backs cryopreservation company
Former Bellamy’s Organic chairman Rob Woolley has popped up as a major shareholder and chair of a biomedical cryopreservation company
Browse our press releases below for our research results and investor news. As well as recent news articles that feature the development of the Vitrafy story.
For media inquiries, please get in touch.
Vitrafy Life Sciences (Vitrafy) announces the appointment of Kate Munnings as the CEO of the Australian biotech company.
Vitrafy Life Sciences Limited (“Vitrafy” or “the Company”) and Texas based BioBridge Global (“BBG “) have collaborated to complete non-clinical viability studies on cryopreserved T-cells, with outstanding results.
Vitrafy Life Sciences announce Sonia Petering, FAICD, as the new Chair of the Australian biotech company.
Vitrafy Life Sciences, one of Australia’s newest biotech companies, is pleased to announce it has received $1,823,449 from the Australian Tax Office under the Research and Development (R&D) Tax Incentive scheme for the 2022 financial year.
Vitrafy Life Sciences has established its Scientific Advisory Board with IVF pioneer Associate Professor John McBain appointed as the inaugural chair.
San Antonio-based BioBridge Global and Australia’s Vitrafy Life Sciences partner to develop new cryopreservation systems for the advancement of human blood services and advanced cellular therapies.
Vitrafy Life Sciences and BioBridge Global, have signed an agreement set to revolutionize cryopreservation supply chains for human blood products and advanced cellular therapies.
Vitrafy Life Sciences biomedical cryopreservation company has closed an oversubscribed IPO capital raise ahead of an anticipated 2021 Australian Securities Exchange (ASX) listing.
The funding round, led by Bell Potter Securities, had initial expectations of raising A$3million but was heavily oversubscribed with the company settling on a A$7.9million raise.
Former Bellamy’s Organic chairman Rob Woolley has popped up as a major shareholder and chair of a biomedical cryopreservation company
San Antonio-based BioBridge Global and Australia’s Vitrafy Life Sciences partner to develop new cryopreservation systems for the advancement of human
A Ballarat-based company improving the preservation of biological matter is going global, with a new partnership in the United States.
Fresh from closing an oversubscribed pre-IPO capital raise last month, cryopreservation company Vitrafy Life Sciences is gearing up for a
Vitrafy Life Sciences has established its Scientific Advisory Board with IVF pioneer Associate Professor John McBain appointed as the inaugural
Vitrafy Life Sciences has established its Scientific Advisory Board with IVF pioneer Associate Professor John McBain appointed as the inaugural chair. As Vitrafy continues to
Fresh from closing an oversubscribed pre-IPO capital raise last month, cryopreservation company Vitrafy Life Sciences is gearing up for a float in the fourth quarter
A Ballarat-based company improving the preservation of biological matter is going global, with a new partnership in the United States. Vitrafy Life Sciences has partnered
San Antonio-based BioBridge Global and Australia’s Vitrafy Life Sciences partner to develop new cryopreservation systems for the advancement of human blood services and advanced cellular
Former Bellamy’s Organic chairman Rob Woolley has popped up as a major shareholder and chair of a biomedical cryopreservation company that has raised $7.9 million
Vitrafy Life Sciences has established its scientific advisory board, with IVF pioneer Associate Professor John McBain appointed as the inaugural chair.
Vitrafy Life Sciences has established its scientific advisory board, with IVF pioneer Associate Professor John McBain appointed as the inaugural chair.
Vitrafy Life Sciences has established its scientific advisory board, with IVF pioneer Associate Professor John McBain appointed as the inaugural chair.